| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 457 |
| 1 | ASPIRIN | 315 |
| 2 | ASPIRIN 325 MG | 310 |
| 3 | ASPIRIN 81 MG | 310 |
| 4 | RITUXIMAB | 197 |
| 5 | TACROLIMUS | 180 |
| 6 | CLOPIDOGREL BISULFATE | 153 |
| 7 | PREDNISONE | 152 |
| 8 | CYCLOSPORINE | 149 |
| 9 | METHYLPREDNISOLONE | 148 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 84 | 0.0471 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 58 | 0.0069 |
| 2 | ACITRETIN | 28 | 0.0057 |
| 3 | ALEMTUZUMAB | 59 | 0.0030 |
| 4 | ACETYLCYSTEINE | 29 | 0.0030 |
| 5 | PRASUGREL HYDROCHLORIDE | 29 | 0.0029 |
| 6 | CARFILZOMIB | 70 | 0.0025 |
| 7 | CLOPIDOGREL | 457 | 0.0023 |
| 8 | MICAFUNGIN SODIUM | 15 | 0.0023 |
| 9 | GEMCITABINE HYDROCHLORIDE | 110 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 510 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 476 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 326 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 213 |
| 4 | Platinum-based Drug [EPC] | 184 |
| 5 | Alkylating Drug [EPC] | 165 |
| 6 | Proteasome Inhibitor [EPC] | 163 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 149 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 140 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 139 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 19 | 0.0032 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 59 | 0.0030 |
| 2 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 3 | Echinocandin Antifungal [EPC] | 16 | 0.0019 |
| 4 | Allylamine Antifungal [EPC] | 14 | 0.0019 |
| 5 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 6 | Proteasome Inhibitor [EPC] | 163 | 0.0014 |
| 7 | Provitamin D2 Compound [EPC] | 41 | 0.0014 |
| 8 | Anti-coagulant [EPC] | 5 | 0.0013 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |